Nobuhiro Tsukamoto
Papers
1
Total Citations
7
H-Index
1
About
Nobuhiro Tsukamoto is a radiation oncologist whose research focuses on the safety and efficacy of advanced radiotherapy techniques, particularly for prostate cancer. His major contributions center on evaluating the toxicity and feasibility of extremely hypofractionated radiotherapy (EHF-RT) using non-isocentric robotic radiosurgery systems, a cutting-edge approach that delivers high-dose radiation in fewer sessions. His most cited work, a 2016 study on rectal toxicity after EHF-RT for early-stage prostate cancer, provides critical insights into minimizing adverse effects while maintaining treatment precision. This study, cited 7 times, has helped shape clinical protocols for low-to-intermediate-risk patients. Tsukamoto’s research is notable for its emphasis on patient safety and treatment optimization, bridging the gap between technological innovation and practical oncology. His work contributes to the growing body of evidence supporting hypofractionation as a viable alternative to conventional radiotherapy, offering patients shorter treatment courses with comparable outcomes. For students and researchers, Tsukamoto’s studies underscore the importance of balancing dose escalation with toxicity management in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1